Philippe Wiesel
Patrimonio netto: - $ in data 30/06/2026
Patrimonio netto: - $ in data 30/06/2026
Philippe Wiesel is the founder of Genexion SA. Currently, Dr. Wiesel is Chief Medical Officer & Executive Vice President at Calliditas Therapeutics Suisse SA since 2010 and Chief Medical Officer at AgomAb Therapeutics NV since 2021.
Formerly, Dr. Wiesel was Medical Director at EMD Serono, Inc., Serono SA, and Serono International SA, and Clinical Development Advisor at Funxional Therapeutics Ltd. Dr. Wiesel earned a doctorate from the University of Lausanne in 1993.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Direttore Tecnico/Scientifico/R&S | 26/05/2011 |
| Società | Posizione | Fine |
|---|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Direttore Tecnico/Scientifico/R&S | - |
Serono International SA | Direttore Tecnico/Scientifico/R&S | - |
Genexion SA | Fondatore | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Direttore Tecnico/Scientifico/R&S | - |
Funxional Therapeutics Ltd.
Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Specializes in the manufacture of cancer and cardiovascular drugs | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
University of Lausanne
University of Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Funxional Therapeutics Ltd.
Funxional Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides drug and therapeutical development services | Health Technology |
Serono International SA | |
Genexion SA | |
AgomAb Therapeutics NV
AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale